Denmark

MinervaX from Denmark secures €54 Million to combat Life-Threatening Group B Streptococcus Infections

Denmark

MinervaX from Denmark secures €54 Million to combat Life-Threatening Group B Streptococcus Infections

Denmark

MinervaX announces 72M EUR financing to advance development of novel vaccine against Group B Streptococcus

MinervaX ApS, a privately held Danish biotechnology company developing a novel vaccine against Group B Streptococcus (GBS), today announces the successful completion of a 72 million EUR financing round.

Denmark

Danish Startup “Whistleblower Software” raises $3M

Denmark

Kollektiv raised €1.5M to build Web3 ecosystem for personal trainers

Denmark

Danish fintech Moneyflow raises €250M in loan financing

Denmark

Neuroscience startup Neurons Inc raises €6M as one of the largest seed rounds in Denmark

The best Articles in our Network

Canada

Kraaft from Fance secures €13M to expand ‘WhatsApp for Construction’ App across Europe

Canada

Moment Energy secures $21.5M CAD to expand EV Battery Repurposing Operations

Germany

Sereact from Germany raises €25M to enhance AI-Powered Robotics for Logistics and Manufacturing

United Kingdom

Aegis Energy secures €118M to develop Clean Energy Hubs for Commercial Vehicles in the UK

Spain

H2SITE secures €36M to tackle Hydrogen Supply Chain Challenges

Canada